Exosome and Microvesicle Research
Exosome isolation and quantification, exosome standards, antibodies and RNA extraction
|
Our exosome and microvesicle research range includes exosome standards, exosome isolation and purification kits and antibodies to mircovesicles that have actually been tested with exosomes in each application.
Some products are highlighted below, but please use the search box above if you are looking for a specific product or email us.
More information on exosome research including highlighted papers and other resources is available on our Exosome Twitter feed: Tweets by NKTSciExosome.
|
|
HansaBioMed’s TFF-MV concentrator allows one-step purification of microvesicles from large volume samples from just a few millilitres to several litres. With a filter cartridge made from polysulfone hollow fibers it can separate different extracellular vesicles (EVs) by size with no clogging. Water, small molecules and small EVs pass through the hollow fibre pores, leaving larger microvesicles (>150 nm) in the cartridge. The larger microvesicles can then be... read more about the TFF-easy and TF-MV concentrators.
|
|
EXO-Prep is a NEW and efficient method for exosome isolation from biofluids (i.e plasma serum and urine) or cell culture supernatant.
|
|
The exosomics range provides solutions for the isolation and selective enrichment of tumour-originating extracellular vesicles (EVs) and exosomes from complex biofluids, providing researchers invaluable solutions to detect early cancer hallmarks in blood samples.
Current liquid biopsy methods generally isolate total nucleic acids from blood but with only low levels of tumour-derived RNA and DNA. However the Exosomics SeleCTEV-DNA and SoRTEV-RNA kits allow the isolation of tumour-derived genetic material without the need for special equipment, such as ultracentrifugation or chromatography. Using unique proprietary affinity methods these kits selectively purify tumour-derived extracellular vesicles and exosomes from which RNA and DNA can then be extracted. Read more about the purification of tumour-originating nucleic acids from tumour enriched EVs and exosomes.
|
